Quadrant Capital Group LLC Neogenomics Inc Transaction History
Quadrant Capital Group LLC
- $1.34 Billion
- Q2 2024
A detailed history of Quadrant Capital Group LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 3,791 shares of NEO stock, worth $54,969. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,791
Previous 4,546
16.61%
Holding current value
$54,969
Previous $71,000
26.76%
% of portfolio
0.0%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$285 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$205 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$127 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$97.6 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$96 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.82B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...